Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors-Reference-Cited by-同舟云学术

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

Published:2013-10-26 Issue:3 Volume:22 Page:679-687
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Henry David,Vadhan-Raj Saroj,Hirsh Vera,von Moos Roger,Hungria Vania,Costa Luis,Woll Penella J,Scagliotti Giorgio,Smith Geoffrey,Feng Amy,Jun Susie,Dansey Roger,Yeh Howard

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-013-2022-1.pdf

Reference26 articles.

1. Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE (2005) Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97:59–69

2. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249s

3. Lipton A (2010) Implications of bone metastases and the benefits of bone-targeted therapy. Semin Oncol 37(Suppl 2):S15–S29

4. Portenoy RK, Lesage P (1999) Management of cancer pain. Lancet 353:1695–1700

5. Mavrogenis AF, Pala E, Romagnoli C, Romantini M, Calabro T, Ruggieri P (2012) Survival analysis of patients with femoral metastases. J Surg Oncol 105:135–141

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study;Journal of Clinical Oncology;2024-08-20

2. Routine use of denosumab for prevention of skeletal-related events in patients with bone metastases from prostate carcinoma in Bulgaria: a prospective observational study;Biotechnology & Biotechnological Equipment;2024-07

3. Bone-modifying agents for bone metastasis in patients with breast cancer;Kosin Medical Journal;2024-06-30

4. Determinants of outcome in cancer patients with medication-related osteonecrosis of the jaw: A 19-year retrospective study;Oral Oncology Reports;2024-06

5. Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review;Medicine;2024-05-24